Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The aristaless-related homeobox gene ARX encodes a paired-type homeodomain transcription factor essential for forebrain interneuron development. Hemizygous loss-of-function and polyalanine expansion mutations in ARX underlie a spectrum of X-linked disorders, including non-syndromic X-linked intellectual disability (Non-syndromic X-linked intellectual disability, NS-XLID).
ARX meets a Moderate ClinGen gene–disease validity for NS-XLID based on at least nine unrelated male probands in nine families with pathogenic variants, segregation in affected male relatives, and concordant functional data.
NS-XLID is inherited in an X-linked recessive manner. In a cohort of 65 Iranian families, one family was found to harbor the recurrent 24 bp duplication, c.428_451dup (p.Gly143_Ala150dup) (PMID:22642246). In a broader screen of 613 individuals with intellectual disability, eight additional families were identified with ARX mutations (1.31%) across polyalanine expansions and homeodomain variants (PMID:21496008). Two affected male cousins with a null variant, c.81C>G (p.Tyr27Ter), demonstrate segregation in a single pedigree (PMID:19738637).
Pathogenic alleles include polyalanine tract expansions (dup24, dup27, dup33), nonsense and frameshift truncations, and homeodomain missense changes. The recurrent c.428_451dup (p.Gly143_Ala150dup) accounts for ~40% of ARX-related cases. Missense mutations cluster in the paired-type homeodomain, correlating with phenotype severity.
ARX operates as a Groucho/TLE-dependent transcriptional repressor. The c.98T>C (p.Leu33Pro) mutation abolishes TLE1 binding and relaxes repression, while polyalanine expansions enhance repression proportional to tract length (PMID:17331656). Homeodomain missense variants disrupt DNA binding and reduce repression of endogenous targets LMO1 and SHOX2 (PMID:22194193).
A knock-in mouse model carrying the human c.428_451dup24 allele exhibits hyperactivity, increased stereotypies, fine motor impairments, interneuron migration defects, and excitatory/inhibitory imbalance in the amygdala, mirroring NS-XLID phenotypes (PMID:29659809).
Combined genetic segregation, recurrent pathogenic variants, robust in vitro functional assays, and an informative mouse model support a Moderate gene–disease association between ARX and NS-XLID. Routine ARX molecular testing is recommended in male patients with familial non-syndromic intellectual disability. Key Take-home: ARX mutations are a clinically actionable cause of NS-XLID with established genetic and functional evidence informing diagnosis.
Gene–Disease AssociationModerateNine probands across nine families, segregation in male relatives, concordant functional data Genetic EvidenceModerateNine pathogenic variants in nine unrelated probands from nine families with X-linked recessive inheritance Functional EvidenceStrongDemonstrated transcriptional repression defects in vitro and phenotype replication in a knock-in mouse model |